LICHEN CHINA LTD- A (LICN)

KYG5479G1082 - Common Stock

0.1604  -0.02 (-9.38%)

Fundamental Rating

5

Overall LICN gets a fundamental rating of 5 out of 10. We evaluated LICN against 80 industry peers in the Professional Services industry. LICN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. LICN does not seem to be growing, but still is valued expensively.



Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year LICN was profitable.
In the past year LICN had a positive cash flow from operations.

1.2 Ratios

The Return On Assets of LICN (10.67%) is better than 81.82% of its industry peers.
LICN has a Return On Equity of 11.10%. This is comparable to the rest of the industry: LICN outperforms 55.84% of its industry peers.
LICN's Return On Invested Capital of 11.52% is fine compared to the rest of the industry. LICN outperforms 70.13% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LICN is in line with the industry average of 18.18%.
The 3 year average ROIC (18.36%) for LICN is well above the current ROIC(11.52%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 10.67%
ROE 11.1%
ROIC 11.52%
ROA(3y)16.41%
ROA(5y)N/A
ROE(3y)18.52%
ROE(5y)N/A
ROIC(3y)18.36%
ROIC(5y)N/A

1.3 Margins

LICN's Profit Margin of 18.48% is amongst the best of the industry. LICN outperforms 88.31% of its industry peers.
LICN's Profit Margin has been stable in the last couple of years.
LICN's Operating Margin of 26.49% is amongst the best of the industry. LICN outperforms 89.61% of its industry peers.
LICN's Operating Margin has improved in the last couple of years.
LICN's Gross Margin of 60.71% is fine compared to the rest of the industry. LICN outperforms 70.13% of its industry peers.
In the last couple of years the Gross Margin of LICN has remained more or less at the same level.
Industry RankSector Rank
OM 26.49%
PM (TTM) 18.48%
GM 60.71%
OM growth 3Y2.47%
OM growth 5YN/A
PM growth 3Y0.13%
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5YN/A

More info and screens

9

2. Health

2.1 Basic Checks

LICN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, LICN has more shares outstanding
There is no outstanding debt for LICN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 4.25 indicates that LICN is not in any danger for bankruptcy at the moment.
LICN has a better Altman-Z score (4.25) than 75.32% of its industry peers.
There is no outstanding debt for LICN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.25
ROIC/WACC1.49
WACC7.73%

2.3 Liquidity

LICN has a Current Ratio of 17.55. This indicates that LICN is financially healthy and has no problem in meeting its short term obligations.
LICN has a better Current ratio (17.55) than 100.00% of its industry peers.
A Quick Ratio of 17.53 indicates that LICN has no problem at all paying its short term obligations.
LICN has a better Quick ratio (17.53) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 17.55
Quick Ratio 17.53

More info and screens

2

3. Growth

3.1 Past

The earnings per share for LICN have decreased strongly by -27.78% in the last year.
The Earnings Per Share has been growing by 9.77% on average over the past years. This is quite good.
Looking at the last year, LICN shows a very negative growth in Revenue. The Revenue has decreased by -15.69% in the last year.
Measured over the past years, LICN shows a quite strong growth in Revenue. The Revenue has been growing by 9.04% on average per year.
EPS 1Y (TTM)-27.78%
EPS 3Y9.77%
EPS 5YN/A
EPS Q2Q%-51.28%
Revenue 1Y (TTM)-15.69%
Revenue growth 3Y9.04%
Revenue growth 5YN/A
Sales Q2Q%13.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 0.55, which indicates a rather cheap valuation of LICN.
LICN's Price/Earnings ratio is rather cheap when compared to the industry. LICN is cheaper than 98.70% of the companies in the same industry.
LICN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.77.
Industry RankSector Rank
PE 0.55
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -1.96

4.3 Compensation for Growth

The decent profitability rating of LICN may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LICN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LICHEN CHINA LTD- A

NASDAQ:LICN (12/18/2024, 3:03:05 PM)

0.1604

-0.02 (-9.38%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.06M
Analysts
Price Target
Short Float %
Short Ratio
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 0.55
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.67%
ROE 11.1%
ROCE
ROIC
ROICexc
ROICexgc
OM 26.49%
PM (TTM) 18.48%
GM 60.71%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 17.55
Quick Ratio 17.53
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-27.78%
EPS 3Y9.77%
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-15.69%
Revenue growth 3Y9.04%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y